Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PFIZER INCPFE · Entity 2863 | Executive Vice President | March 03, 2026 | March 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PFIZER INC
Report date March 03, 2026 · Filed March 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $26.58 · Expires 2031-03-03 | Direct | 151,576 |
Reported balance
After 2026-03-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-03 · Grant · Acquired 151,576 · Balance 151,576 F1: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 03, 2026 Filed Mar 5, 2026 22:25 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 151,576 | $0.00 Strike: $26.58 | $0.00 |
DisclosureSEC source: 0001225208-26-003310 · doc4.xml · derivative · entry 1 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,576 Underlying: Common Stock · 151,576 shares Expires 2031-03-03 F1 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F1 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 23:34 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 3,503 | $27.10 | $94,931.30 |
DisclosureSEC source: 0001225208-26-002816 · doc4.xml · nonDerivative · entry 4 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,308 F5 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 23:34 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 37,925 | $0.00 Strike: $33.82 | $0.00 |
DisclosureSEC source: 0001225208-26-002816 · doc4.xml · derivative · entry 5 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,925 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F6 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 23:34 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 36,044 | $26.92 | $970,304.48 |
DisclosureSEC source: 0001225208-26-002816 · doc4.xml · nonDerivative · entry 3 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,811 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 23:34 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 679 | $27.09 | $18,394.11 |
DisclosureSEC source: 0001225208-26-002816 · doc4.xml · nonDerivative · entry 2 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,855 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 23:34 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 37,925 | $33.82 | $1,282,623.50 |
DisclosureSEC source: 0001225208-26-002816 · doc4.xml · nonDerivative · entry 1 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| March 04, 2025 Filed Mar 6, 2025 18:49 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 289,196 | $0.00 Strike: $25.75 | $0.00 |
DisclosureSEC source: 0001225208-25-003070 · doc4.xml · derivative · entry 1 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 289,196 Underlying: Common Stock · 289,196 shares Expires 2030-03-04 F1 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F1 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 22:37 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 48,419 | $0.00 Strike: $31.31 | $0.00 |
DisclosureSEC source: 0001225208-25-002706 · doc4.xml · derivative · entry 4 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 48,419 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 22:37 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 45,347 | $26.06 | $1,181,742.82 |
DisclosureSEC source: 0001225208-25-002706 · doc4.xml · nonDerivative · entry 3 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,958 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 22:37 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,108 | $26.10 | $28,918.80 |
DisclosureSEC source: 0001225208-25-002706 · doc4.xml · nonDerivative · entry 2 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,305 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 22:37 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 48,419 | $31.31 | $1,515,998.89 |
DisclosureSEC source: 0001225208-25-002706 · doc4.xml · nonDerivative · entry 1 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,413 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 17:46 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 3,220 | $26.42 | $85,072.40 |
DisclosureSEC source: 0001225208-25-002613 · doc4.xml · nonDerivative · entry 1 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,994 F1 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 22, 2025 Filed Feb 26, 2025 00:38 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 11,125 | $0.00 Strike: $30.17 | $0.00 |
DisclosureSEC source: 0001225208-25-002413 · doc4.xml · derivative · entry 4 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,125 shares Expires 2025-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2025 Filed Feb 26, 2025 00:38 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 9,925 | $26.08 | $258,844.00 |
DisclosureSEC source: 0001225208-25-002413 · doc4.xml · nonDerivative · entry 3 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,214 F4 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F5 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 22, 2025 Filed Feb 26, 2025 00:38 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 497 | $26.30 | $13,071.10 |
DisclosureSEC source: 0001225208-25-002413 · doc4.xml · nonDerivative · entry 2 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,139 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. F3 · price: Price is the closing price of Pfizer common stock on February 21, 2025. Read SEC document |
| February 22, 2025 Filed Feb 26, 2025 00:38 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 11,125 | $30.17 | $335,641.25 |
DisclosureSEC source: 0001225208-25-002413 · doc4.xml · nonDerivative · entry 1 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,636 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| September 12, 2024 Filed Sep 16, 2024 16:57 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 34,234 | $0.00 Strike: $45.96 | $0.00 |
DisclosureSEC source: 0001225208-24-008705 · doc4.xml · derivative · entry 4 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,234 Underlying: Common Stock · 34,234 shares Expires 2029-02-24 F1 · shares: Represents the number of shares of issuer common stock underlying stock appreciation rights ("total shareholder return units" or "TSRUs") eligible for modification ("Eligible TSRUs") pursuant to the issuer's one-time offer to modify Eligible TSRUs (the "Modification Offer") described in the Tender Offer Statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on August 12, 2024 (as amended, the "Schedule TO") that the reporting person elected to modify. The Modification Offer provided eligible participants the opportunity to elect to modify certain outstanding TSRUs to extend the dates upon which the awards vest and settle by two years (the "Modified TSRUs"). The grant price and number of shares underlying the Modified TSRUs remain unchanged. F2 · derivative.expiration_date: Reflects a modification to the settlement date of the Modified TSRUs pursuant to the Modification Offer. The grant price and number of shares underlying the Modified TSRUs remain unchanged. Read SEC document |
| September 12, 2024 Filed Sep 16, 2024 16:57 UTC | PFIZER INC PFE · Entity 2863 | Disposition to issuerStock Appreciation Rights · Derivative | 34,234 | $0.00 Strike: $45.96 | $0.00 |
DisclosureSEC source: 0001225208-24-008705 · doc4.xml · derivative · entry 3 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 34,234 shares Expires 2027-02-24 F1 · shares: Represents the number of shares of issuer common stock underlying stock appreciation rights ("total shareholder return units" or "TSRUs") eligible for modification ("Eligible TSRUs") pursuant to the issuer's one-time offer to modify Eligible TSRUs (the "Modification Offer") described in the Tender Offer Statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on August 12, 2024 (as amended, the "Schedule TO") that the reporting person elected to modify. The Modification Offer provided eligible participants the opportunity to elect to modify certain outstanding TSRUs to extend the dates upon which the awards vest and settle by two years (the "Modified TSRUs"). The grant price and number of shares underlying the Modified TSRUs remain unchanged. Read SEC document |
| September 12, 2024 Filed Sep 16, 2024 16:57 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 45,920 | $0.00 Strike: $42.30 | $0.00 |
DisclosureSEC source: 0001225208-24-008705 · doc4.xml · derivative · entry 2 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,920 Underlying: Common Stock · 45,920 shares Expires 2030-02-23 F1 · shares: Represents the number of shares of issuer common stock underlying stock appreciation rights ("total shareholder return units" or "TSRUs") eligible for modification ("Eligible TSRUs") pursuant to the issuer's one-time offer to modify Eligible TSRUs (the "Modification Offer") described in the Tender Offer Statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on August 12, 2024 (as amended, the "Schedule TO") that the reporting person elected to modify. The Modification Offer provided eligible participants the opportunity to elect to modify certain outstanding TSRUs to extend the dates upon which the awards vest and settle by two years (the "Modified TSRUs"). The grant price and number of shares underlying the Modified TSRUs remain unchanged. F2 · derivative.expiration_date: Reflects a modification to the settlement date of the Modified TSRUs pursuant to the Modification Offer. The grant price and number of shares underlying the Modified TSRUs remain unchanged. Read SEC document |
| September 12, 2024 Filed Sep 16, 2024 16:57 UTC | PFIZER INC PFE · Entity 2863 | Disposition to issuerStock Appreciation Rights · Derivative | 45,920 | $0.00 Strike: $42.30 | $0.00 |
DisclosureSEC source: 0001225208-24-008705 · doc4.xml · derivative · entry 1 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,920 shares Expires 2028-02-23 F1 · shares: Represents the number of shares of issuer common stock underlying stock appreciation rights ("total shareholder return units" or "TSRUs") eligible for modification ("Eligible TSRUs") pursuant to the issuer's one-time offer to modify Eligible TSRUs (the "Modification Offer") described in the Tender Offer Statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on August 12, 2024 (as amended, the "Schedule TO") that the reporting person elected to modify. The Modification Offer provided eligible participants the opportunity to elect to modify certain outstanding TSRUs to extend the dates upon which the awards vest and settle by two years (the "Modified TSRUs"). The grant price and number of shares underlying the Modified TSRUs remain unchanged. Read SEC document |
| February 27, 2024 Filed Feb 28, 2024 22:00 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 110,756 | $0.00 Strike: $26.89 | $0.00 |
DisclosureSEC source: 0001225208-24-003205 · doc4.xml · derivative · entry 2 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,756 Underlying: Common Stock · 110,756 shares Expires 2031-02-27 F2 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F2 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 27, 2024 Filed Feb 28, 2024 22:00 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 125,347 | $0.00 Strike: $26.89 | $0.00 |
DisclosureSEC source: 0001225208-24-003205 · doc4.xml · derivative · entry 1 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,347 Underlying: Common Stock · 125,347 shares Expires 2029-02-27 F1 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F1 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 26, 2024 Filed Feb 27, 2024 18:47 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 6,063 | $27.18 | $164,792.34 |
DisclosureSEC source: 0001225208-24-003056 · doc4.xml · nonDerivative · entry 5 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,463 F5 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 25, 2024 Filed Feb 27, 2024 18:47 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 2,992 | $27.76 | $83,057.92 |
DisclosureSEC source: 0001225208-24-003056 · doc4.xml · nonDerivative · entry 4 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,526 F5 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). F6 · price: Price is the closing price of Pfizer common stock on February 23, 2024. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 18:47 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 12,412 | $0.00 Strike: $27.34 | $0.00 |
DisclosureSEC source: 0001225208-24-003056 · doc4.xml · derivative · entry 6 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,412 shares Expires 2024-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F7 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 18:47 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 10,031 | $27.37 | $274,548.47 |
DisclosureSEC source: 0001225208-24-003056 · doc4.xml · nonDerivative · entry 3 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,518 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 18:47 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 859 | $27.76 | $23,845.84 |
DisclosureSEC source: 0001225208-24-003056 · doc4.xml · nonDerivative · entry 2 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,549 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 18:47 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 12,412 | $27.34 | $339,344.08 |
DisclosureSEC source: 0001225208-24-003056 · doc4.xml · nonDerivative · entry 1 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,408 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 27, 2023 Filed Feb 28, 2023 22:52 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 3,081 | $40.78 | $125,643.18 |
DisclosureSEC source: 0001225208-23-002987 · doc4.xml · nonDerivative · entry 4 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,874 F6 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 25, 2023 Filed Feb 28, 2023 22:52 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 14,178 | $0.00 Strike: $22.89 | $0.00 |
DisclosureSEC source: 0001225208-23-002987 · doc4.xml · derivative · entry 5 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,178 shares Expires 2023-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F7 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 25, 2023 Filed Feb 28, 2023 22:52 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 6,305 | $43.44 | $273,889.20 |
DisclosureSEC source: 0001225208-23-002987 · doc4.xml · nonDerivative · entry 3 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,955 F4 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F5 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 25, 2023 Filed Feb 28, 2023 22:52 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 2,839 | $41.75 | $118,528.25 |
DisclosureSEC source: 0001225208-23-002987 · doc4.xml · nonDerivative · entry 2 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,260 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. F3 · price: Price is the closing price of Pfizer common stock on February 24, 2023. Read SEC document |
| February 25, 2023 Filed Feb 28, 2023 22:52 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 14,178 | $22.89 | $324,534.42 |
DisclosureSEC source: 0001225208-23-002987 · doc4.xml · nonDerivative · entry 1 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,099 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 23, 2023 Filed Feb 25, 2023 01:52 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 39,965 | $0.00 Strike: $42.30 | $0.00 |
DisclosureSEC source: 0001225208-23-002816 · doc4.xml · derivative · entry 6 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,965 Underlying: Common Stock · 39,965 shares Expires 2030-02-23 F6 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F6 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 23, 2023 Filed Feb 25, 2023 01:52 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 45,920 | $0.00 Strike: $42.30 | $0.00 |
DisclosureSEC source: 0001225208-23-002816 · doc4.xml · derivative · entry 5 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,920 Underlying: Common Stock · 45,920 shares Expires 2028-02-23 F5 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F5 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 01:52 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 13,307 | $0.00 Strike: $30.17 | $0.00 |
DisclosureSEC source: 0001225208-23-002816 · doc4.xml · derivative · entry 4 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,307 shares Expires 2023-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F5 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 01:52 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 8,101 | $43.70 | $354,013.70 |
DisclosureSEC source: 0001225208-23-002816 · doc4.xml · nonDerivative · entry 3 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,921 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 01:52 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,935 | $42.38 | $82,005.30 |
DisclosureSEC source: 0001225208-23-002816 · doc4.xml · nonDerivative · entry 2 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,022 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 01:52 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 13,307 | $30.17 | $401,472.19 |
DisclosureSEC source: 0001225208-23-002816 · doc4.xml · nonDerivative · entry 1 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,957 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 28, 2022 Filed Mar 1, 2022 21:03 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,384 | $46.94 | $64,964.96 |
DisclosureSEC source: 0001225208-22-003666 · doc4.xml · nonDerivative · entry 4 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,013 F6 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 26, 2022 Filed Mar 1, 2022 21:03 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 12,340 | $0.00 Strike: $25.60 | $0.00 |
DisclosureSEC source: 0001225208-22-003666 · doc4.xml · derivative · entry 5 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,340 shares Expires 2022-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2022 Filed Mar 1, 2022 21:03 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 5,761 | $50.64 | $291,737.04 |
DisclosureSEC source: 0001225208-22-003666 · doc4.xml · nonDerivative · entry 3 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,397 F4 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F5 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 26, 2022 Filed Mar 1, 2022 21:03 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 2,372 | $47.72 | $113,191.84 |
DisclosureSEC source: 0001225208-22-003666 · doc4.xml · nonDerivative · entry 2 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,158 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. F3 · price: Price is the closing price of Pfizer common stock on February 25, 2022. Read SEC document |
| February 26, 2022 Filed Mar 1, 2022 21:03 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 12,340 | $25.60 | $315,904.00 |
DisclosureSEC source: 0001225208-22-003666 · doc4.xml · nonDerivative · entry 1 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,530 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 24, 2022 Filed Feb 25, 2022 23:23 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 30,109 | $0.00 Strike: $45.96 | $0.00 |
DisclosureSEC source: 0001225208-22-003470 · doc4.xml · derivative · entry 6 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,109 Underlying: Common Stock · 30,109 shares Expires 2029-02-24 F6 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F6 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 24, 2022 Filed Feb 25, 2022 23:23 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 34,234 | $0.00 Strike: $45.96 | $0.00 |
DisclosureSEC source: 0001225208-22-003470 · doc4.xml · derivative · entry 5 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,234 Underlying: Common Stock · 34,234 shares Expires 2027-02-24 F5 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F5 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 23:23 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 14,952 | $0.00 Strike: $27.34 | $0.00 |
DisclosureSEC source: 0001225208-22-003470 · doc4.xml · derivative · entry 4 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,952 shares Expires 2022-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F5 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 23:23 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 7,401 | $51.28 | $379,523.28 |
DisclosureSEC source: 0001225208-22-003470 · doc4.xml · nonDerivative · entry 3 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,190 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 23:23 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 2,927 | $46.87 | $137,188.49 |
DisclosureSEC source: 0001225208-22-003470 · doc4.xml · nonDerivative · entry 2 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,591 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 23:23 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 14,952 | $27.34 | $408,787.68 |
DisclosureSEC source: 0001225208-22-003470 · doc4.xml · nonDerivative · entry 1 McDermott Michael · CIK 0001902464 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.